SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Seres Therapeutics, Inc. (NASDAQ: MCRB) and Encourages Investors to Contact the Firm
November 11, 2023 08:27 ET
|
Kaskela Law
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Seres Therapeutics, Inc. (NASDAQ: MCRB) (“Seres”) on behalf of the company’s investors. Since...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Selecta Biosciences, Inc. (NASDAQ: SELB) and Encourages Investors to Contact the Firm
November 11, 2023 08:26 ET
|
Kaskela Law
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Selecta Biosciences, Inc. (NASDAQ: SELB) (“Selecta”) on behalf of the company’s investors. Since...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Rekor Systems, Inc. (NASDAQ: REKR) and Encourages Investors to Contact the Firm
November 11, 2023 08:24 ET
|
Kaskela Law
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Rekor Systems, Inc. (NASDAQ: REKR) (“Rekor”) on behalf of the company’s investors. Since August...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ProPhase Labs, Inc. (NASDAQ: PRPH) and Encourages Investors to Contact the Firm
November 11, 2023 08:23 ET
|
Kaskela Law
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”) on behalf of the company’s investors. Since May...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Precision BioSciences, Inc. (NASDAQ: DTIL) and Encourages Investors to Contact the Firm
November 11, 2023 08:22 ET
|
Kaskela Law
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Precision BioSciences, Inc. (NASDAQ: DTIL) (“Precision”) on behalf of the company’s investors. ...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) and Encourages Investors to Contact the Firm
November 11, 2023 08:18 ET
|
Kaskela Law
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) (“Phathom”) on behalf of the company’s investors. ...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Ooma, Inc. (NYSE: OOMA) and Encourages Investors to Contact the Firm
November 11, 2023 08:16 ET
|
Kaskela Law
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Ooma, Inc. (NYSE: OOMA) (“Ooma”) on behalf of the company’s investors. Since June 2023, shares...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Nkarta, Inc. (NASDAQ: NKTX) and Encourages Investors to Contact the Firm
November 11, 2023 08:15 ET
|
Kaskela Law
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Nkarta, Inc. (NASDAQ: NKTX) (“Nkarta”) on behalf of the company’s investors. Since June 2023,...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Medifast, Inc. (NYSE: MED) and Encourages Investors to Contact the Firm
November 11, 2023 08:12 ET
|
Kaskela Law
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Medifast, Inc. (NYSE: MED) (“Medifast”) on behalf of the company’s investors. Since July 2023,...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Lyra Therapeutics, Inc. (NASDAQ: LYRA) and Encourages Investors to Contact the Firm
November 11, 2023 08:11 ET
|
Kaskela Law
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Lyra Therapeutics, Inc. (NASDAQ: LYRA) (“Lyra”) on behalf of the company’s investors. Since August...